Cargando…

Vitamin D inhibits the proliferation of Oral Squamous Cell Carcinoma by suppressing lncRNA LUCAT1 through the MAPK pathway

Background: Oral squamous cell carcinoma (OSCC) is the most common type of oral cancer worldwide. Recent studies have suggested that vitamin D (VitD) is associated with a reduced risk of many chronic illnesses, including cancer. However, the role of vitamin D in OSCC has rarely been reported. Materi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Tingting, Guo, Ying, Huang, Zixian, Zhang, Qianyu, Huang, Zhuoshan, Zhang, Yin, Huang, Zhiquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477417/ https://www.ncbi.nlm.nih.gov/pubmed/32922538 http://dx.doi.org/10.7150/jca.45389

Ejemplares similares

Nucleus‐specific RNAi nanoplatform for targeted regulation of nuclear lncRNA function and effective cancer therapy
por: Huang, Zixian, et al.
Publicado: (2022)

Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3
por: Huang, Zixian, et al.
Publicado: (2019)

LncRNA LUCAT1 as a novel prognostic biomarker for patients with papillary thyroid cancer
por: Luzón-Toro, B., et al.
Publicado: (2019)

Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3
por: Huang, Zixian, et al.
Publicado: (2020)

LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR‐539
por: Nai, Yongjun, et al.
Publicado: (2019)

LncRNA LUCAT1 as a Plasma Biomarker for Assessing Disease Activity in Adult Patients with Crohn's Disease
por: Kuai, Xiao-yi, et al.
Publicado: (2021)

LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702
por: Mou, Exian, et al.
Publicado: (2019)

The lncRNA LUCAT1 is elevated in inflammatory disease and restrains inflammation by regulating the splicing and stability of NR4A2
por: Vierbuchen, Tim, et al.
Publicado: (2022)

LncRNA GAS8‐AS1 downregulates lncRNA NEAT1 to inhibit glioblastoma cell proliferation
por: Wu, Xiaoming, et al.
Publicado: (2021)

Study of the biological function of LncRNA LUCAT1 on cervical cancer cells by targeting miR-199b-5p
por: Yang, Ting, et al.
Publicado: (2020)

Silencing of LncRNA AFAP1-AS1 Inhibits Cell Proliferation in Oral Squamous Cancer by Suppressing CCNA2
por: Li, Tao, et al.
Publicado: (2021)

LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15
por: Liu, Yun, et al.
Publicado: (2020)

Knockdown of LncRNA PANDAR by CRISPR-dCas9 Decreases Proliferation and Increases Apoptosis in Oral Squamous Cell Carcinoma
por: Jia, Tingting, et al.
Publicado: (2021)

Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling
por: Huang, Zixian, et al.
Publicado: (2023)

lncRNA LINC-PINT is downregulated in melanoma and regulates cell proliferation by downregulating lncRNA BANCR
por: Huang, Qing, et al.
Publicado: (2019)

Retraction: Study of the biological function of LncRNA LUCAT1 on cervical cancer cells by targeting miR-199b-5p
Publicado: (2021)

Correction: Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling
por: Huang, Zixian, et al.
Publicado: (2023)

Targeting lncRNA PSMA3-AS1, a Prognostic Marker, Suppresses Malignant Progression of Oral Squamous Cell Carcinoma
por: Cao, Xinghua, et al.
Publicado: (2021)

LUCAT1 as an oncogene in tongue squamous cell carcinoma by targeting miR‐375 expression
por: Zhang, Kai, et al.
Publicado: (2021)

Expression of Concern: Study of the biological function of LncRNA LUCAT1 on cervical cancer cells by targeting miR-199b-5p
Publicado: (2020)

Downregulation of lncRNA NEAT1 inhibits the proliferation of human cutaneous squamous cell carcinoma in vivo and in vitro
por: Gong, Zhenhua, et al.
Publicado: (2022)

The lncRNA TUG1 modulates proliferation in trophoblast cells via epigenetic suppression of RND3
por: Xu, Yetao, et al.
Publicado: (2017)

The long noncoding RNA LUCAT1 promotes colorectal cancer cell proliferation by antagonizing Nucleolin to regulate MYC expression
por: Wu, Runliu, et al.
Publicado: (2020)

lncRNA LUCAT1/ELAVL1/LIN28B/SOX2 Positive Feedback Loop Promotes Cell Stemness in Triple-Negative Breast Cancer
por: Xia, Li, et al.
Publicado: (2022)

LncRNA PTCSC3 inhibits cell proliferation in laryngeal squamous cell carcinoma by down-regulating lncRNA HOTAIR
por: Xiao, Dong, et al.
Publicado: (2019)

LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression
por: Wang, Xiaoyan, et al.
Publicado: (2019)

The role of lncRNA MALAT1 in the regulation of hepatocyte proliferation during liver regeneration
por: Li, Cuicui, et al.
Publicado: (2017)

Identification of cancer hallmark‐associated gene and lncRNA cooperative regulation pairs and dictate lncRNA roles in oral squamous cell carcinoma
por: Lin, Ken, et al.
Publicado: (2020)

lncRNA NR4A1AS Upregulates miR-221 Through Demethylation to Promote Cell Proliferation in Oral Squamous Cell Carcinoma
por: Yang, Liuqing, et al.
Publicado: (2020)

Downregulation of Long Noncoding RNA LUCAT1 Suppresses the Migration and Invasion of Bladder Cancer by Targeting miR-181c-5p
por: Chen, Yifan, et al.
Publicado: (2020)

LncRNA‐422 suppresses the proliferation and growth of colorectal cancer cells by targeting SFPQ
por: Meng, Yixuan, et al.
Publicado: (2022)

LncRNA NRON promotes the proliferation, metastasis and EMT process in bladder cancer
por: Xiong, Tiefu, et al.
Publicado: (2020)

Carvacrol suppresses proliferation and invasion in human oral squamous cell carcinoma
por: Dai, Wei, et al.
Publicado: (2016)

Cuproptosis-related lncRNA SNHG16 as a biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma
por: Han, Baoai, et al.
Publicado: (2023)

The lncRNA TDRG1 promotes cell proliferation, migration and invasion by targeting miR-326 to regulate MAPK1 expression in cervical cancer
por: Jiang, Hui, et al.
Publicado: (2019)

LncRNA ZEB1‐AS1 down‐regulation suppresses the proliferation and invasion by inhibiting ZEB1 expression in oesophageal squamous cell carcinoma
por: Zhao, Yan, et al.
Publicado: (2019)

The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis
por: Weng, Nuo-Qing, et al.
Publicado: (2020)

CD79A work as a potential target for the prognosis of patients with OSCC: analysis of immune cell infiltration in oral squamous cell carcinoma based on the CIBERSORTx deconvolution algorithm
por: Yao, Shucong, et al.
Publicado: (2023)

Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma
por: Yu, Jun, et al.
Publicado: (2019)

LncRNA ELF3-AS1 is involved in the regulation of oral squamous cell carcinoma cell proliferation by reprogramming glucose metabolism
por: Chu, Hongxing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dnkunq1t8247mq88t620mpvljr